Uptake and transfection efficiency of PEGylated cationic liposome-DNA complexes with and without RGD-tagging

Biomaterials

Volumn 35, Issue 18, 2014, Pages 4996-5005

  Majzoub, Ramsey N ^a,b   Chan, Chia Ling ^a,b,c,d   Ewert, Kai K ^a,b   Silva, Bruno F B ^a,b,e   Liang, Keng S ^d,f   Jacovetty, Erica L ^g   Carragher, Bridget ^g   Potter, Clinton S ^g   Safinya, Cyrus R ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Santa Barbara   (United States)

^c INSTITUTE OF PHYSICS   (Taiwan)

^d NATIONAL SYNCHROTRON RADIATION RESEARCH CENTER   (Taiwan)

^e LUND UNIVERSITY   (Sweden)

^f NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^g SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Gene therapy; Liposome; Live cell imaging; Nanoparticle; Polyethylene glycol; RGD peptide

Indexed keywords

CELL MEMBRANES; CYTOLOGY; DNA; EFFICIENCY; GENE THERAPY; GENE TRANSFER; GRAFTING (CHEMICAL); LIPIDS; LIPOSOMES; NANOPARTICLES; PEPTIDES; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES;

CELLULAR ATTACHMENTS; ELECTROSTATIC BINDING; ENDOSOMAL ESCAPES; LIVE-CELL IMAGING; RGD PEPTIDE; STABILIZED NANOPARTICLES; STERIC STABILIZATION; TRANSFECTION EFFICIENCY;

SYNTHESIS (CHEMICAL);

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; ARGINYLGLYCYLASPARTIC ACID; DIOLEOYLPHOSPHATIDYLCHOLINE; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; LIPOSOME; MACROGOL 2000; NANOPARTICLE; ARGINYL-GLYCYL-ASPARTIC ACID; CATION; DNA; LIPID; MACROGOL DERIVATIVE; OLIGOPEPTIDE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CATIONIC LIPOSOME DNA COMPLEX; CELL ADHESION; CELL MEMBRANE; CELL SURFACE; COMPLEX FORMATION; CONTROLLED STUDY; DENSITY; DNA TRANSFECTION; ENDOSOME; IN VITRO STUDY; LIPOSOMAL GENE DELIVERY SYSTEM; MOLECULAR INTERACTION; MOLECULAR MODEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STEREOSPECIFICITY; ANIMAL; CELL LINE; CHEMISTRY; ELECTRON MICROSCOPY; GENE THERAPY; GENETIC TRANSFECTION; STATIC ELECTRICITY;

ANIMALS; CATIONS; CELL ADHESION; CELL LINE; DNA; GENETIC THERAPY; LIPIDS; LIPOSOMES; MICE; MICROSCOPY, ELECTRON; NANOPARTICLES; OLIGOPEPTIDES; POLYETHYLENE GLYCOLS; STATIC ELECTRICITY; TRANSFECTION;

EID: 84897916261     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.03.007     Document Type: Article

References (59)

1. Guo X., Huang L. Recent advances in nonviral vectors for gene delivery. Acc Chem Res 2012, 45:971-979.
2. Salcher E., Wagner E. Chemically programmed polymers for targeted DNA and siRNA transfection. Top Curr Chem 2010, 296:227-249.
3. Sioud M. Therapeutic siRNAs. Trends Pharmacol Sci 2004, 25:22-28.
4. Caplen N.J. RNAi as a gene therapy approach. Expert Opin Biol Ther 2003, 3:575-586.
5. Yin J.Y., Ma Z.Y., Selliah N., Shivers D.K., Cron R.Q., Finkel T.H. Effective gene suppression using small interfering RNA in hard-to-transfect human T cells. J Immunol Methods 2006, 312:1-11.
6. Topics in current chemistry. Nucleic acid transfection 2010, vol. 296. Springer, Heidelberg. W. Bielke, C. Erbacher (Eds.).
7. Ewert K.K., Zidovska A., Ahmad A., Bouxsein N.F., Evans H.M., McAllister C.S., et al. Cationic lipid-nucleic acid complexes for gene delivery and silencing: pathways and mechanisms for plasmid DNA and siRNA. Top Curr Chem 2010, 296:191-226.
8. Advances in genetics. Non-viral vectors for gene therapy, part I 2005, vol. 53. Elsevier Academic Press, San Diego. 2nd ed. L. Huang, M.C. Hung, E. Wagner (Eds.).
9. Li S.D., Huang L. Gene therapy progress and prospects: non-viral gene therapy by systemic delivery. Gene Ther 2006, 13:1313-1319.
10. Davis M.E. The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. Mol Pharm 2009, 6:659-668.
11. Ewert K., Ahmad A., Evans H.M., Safinya C.R. Cationic lipid-DNA complexes for non-viral gene therapy: relating supramolecular structures to cellular pathways. Expert Opin Biol Ther 2005, 5:33-53.
12. Ginn S.L., Alexander I.E., Edelstein M.L., Abedi M.R., Wixon J. Gene therapy clinical trials worldwide to 2012 - an update. J Gene Med 2013, 15:65-77.
13. Gene therapy clinical trials worldwide. J Gene Med 2013, Online resource provided by the, Available from: URL, [accessed date 02.12.13]. http://www.wiley.com/legacy/wileychi/genmed/clinical/.
14. Yi Y., Hahm S.H., Lee K.H. Retroviral gene therapy: safety issues and possible solutions. Curr Gene Ther 2005, 5:25-35.
15. Young L., Mautner V. The promise and potential hazards of adenovirus gene therapy. Gut 2001, 48:733-736.
16. Hacein-Bey-Abina S., von Kalle C., Schmidt M., Le Deist F., Wulffraat N., McIntyre E., et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2003, 348:255-256.
17. Hacein-Bey-Abina S., von Kalle C., Schmidt M., McCormack M., Wulffraat N., Leboulch P., et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003, 302:415-419.
18. Raper S., Chirmule N., Lee F., Wivel N., Bagg A., Gao G., et al. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab 2003, 80:148-158.
19. Willard H.F. Artifical chromosomes coming to life. Science 2000, 290:1308.
20. Lin A.J., Slack N.L., Ahmad A., George C.X., Samuel C.E., Safinya C.R. Three-dimensional imaging of lipid gene-carriers: membrane charge density controls universal transfection behavior in lamellar cationic liposome-DNA complexes. Biophys J 2003, 84:3307-3316.
21. Suh J., Choy K.L., Lai S.K., Suk J.S., Tang B., Prabhu S., et al. PEGylation of nanoparticles improves their cytoplasmic transport. Int J Nanomedicine 2007, 2:1-7.
22. Schwake G., Youssef S., Kuhr J.T., Gude S., David M.P., Mendoza E., et al. Predictive modeling of non-viral gene transfer. Biotechnol Bioeng 2010, 105:805-813.
23. Plank C., Mechtler K., Szoka F.C., Wagner E. Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Hum Gene Ther 1996, 7:1437-1446.
24. Fenske D.B., MacLachlan I., Cullis P.R. Stabilized plasmid-lipid particles: a systemic gene therapy vector. Methods Enzymol 2002, 346:36-71.
25. Martin-Herranz A., Ahmad A., Evans H.M., Ewert K.K., Schulze U., Safinya C.R. Surface functionalized cationic lipid-DNA complexes for gene delivery: PEGylated lamellar complexes exhibit distinct DNA-DNA interaction regimes. Biophys J 2004, 86:1160-1168.
26. Gjetting T., Arildsen N.S., Christensen C.L., Poulsen T.T., Roth J.A., Handlos V.N., et al. In vitro and in vivo effects of polyethylene glycol (PEG)-modified lipid in DOTAP/cholesterol-mediated gene transfection. Int J Nanomedicine 2010, 9:371-383.
27. Immordino M.L., Dosio F., Cattel L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomedicine 2006, 1:297-315.
28. Sadzuka Y., Kishi K., Hirota S., Sonobe T. Effect of polytheyleneglycol (PEG) chain on cell uptake of PEG-modified liposomes. J Liposome Res 2003, 13:157-172.
29. Kibria G., Hatakeyama H., Ohga N., Hida K., Harashima H. Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery. J Control Release 2011, 153:141-148.
30. Sakaguchi N., Kojima C., Harada A., Koiwai K., Shimizu K., Emi N., et al. Enhancement of transfection activity of lipoplexes by complexation with transferrin-bearing fusogenic polymer-modified liposomes. Int J Pharm 2006, 325:186-190.
31. Bunuales M., Duzgunes N., Zalba S., Garrido M.J., Larduya I. Efficient gene delivery by EGF lipoplexes in vitro and in vivo. Nanomedicine (Lond) 2011, 6:89-98.
32. Yu W., Pirollo K.F., Rait A., Yu B., Xiang L.M., Huang W.Q., et al. A sterically stabilized immunolipoplex for systemic administration of a therapeutic gene. Gene Ther 2004, 11:1434-1440.
33. Torchilin V.P., Levchenko T.S., Rammohan R., Volodina N., Papahadjopoulos-Sternberg B., D'Souza G.G.M. Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes. Proc Natl Acad Sci U S A 2003, 100:1972-1977.
34. Ruoslahti E., Bhatia S.N., Sailor M.J. Targeting of drugs and nanoparticles to tumors. J Cell Biol 2010, 188:759-768.
35. Temming K., Schiffelers R.M., Molema G., Kok R.J. RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature. Drug Resist Updat 2005, 8:381-402.
36. Ruoslati E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 1996, 12:697-715.
37. Mas-Moruno C., Rechenmacher F., Kessler H. Cilengitide: the first anti-angiogenic small molecule drug candidate; design, synthesis and clinical evaluation. Anticancer Agents Med Chem 2010, 10:753-768.
38. Ahmad A., Evans H.M., Ewert K.K., George C.X., Samuel C.E., Safinya C.R. New multivalent cationic lipids reveal bell curve for transfection efficiency versus membrane charge density: lipid-DNA complexes for gene delivery. J Gene Med 2005, 7:739-748.
39. Suloway C., Pulokas J., Fellmann D., Cheng A., Guerra F., Quispe J., et al. Automated molecular microscopy: the new Leginon system. J Struct Biol 2005, 151:41-60.
40. Rädler J.O., Koltover I., Salditt T., Safinya C.R. Structure of DNA-cationic liposomes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes. Science 1997, 275:810-814.
41. Chan C.L., Majzoub R.N., Shirazi R.S., Ewert K.K., Chen Y.J., Liang K.S., et al. Endosomal escape and transfection efficiency of PEGylated cationic liposome-DNA complexes prepared with an acid-labile PEG-Lipid. Biomaterials 2012, 33:4928-4935.
42. Suh J., Wirtz J., Hanes J. Efficient active transport of gene nanocarriers to the cell nucleus. Proc Natl Acad Sci U S A 2004, 100:598-602.
43. Koltover I., Salditt T., Safinya C.R. Phase diagram, stability, and overcharging of lamellar cationic lipid-DNA self-assembled complexes. Biophys J 1999, 77:915-924.
44. Sanders N.N., Peeters L., Lentacker I., Demeester J., De Smedt S.C. Wanted and unwanted properties of surface PEGylated nucleic acid nanoparticles in ocular gene transfer. J Control Release 2007, 122:226-235.
45. Remaut K., Lucas B., Braeckmans K., Demeester J., De Smedt S.C. PEGylation of liposomes favors the endosomal degradation of the delivered phosphodiester oligonucleotides. J Control Release 2007, 117:256-266.
46. Hasegawa S., Hirashima N., Nakanishi M. Microtubule involvement in the intracellular dynamics for gene transfection mediated by cationic liposomes. Gene Ther 2001, 8:1669-1673.
47. Pankov R., Markovska T., Antonov P., Ivanova L., Momchilova A. The plasma membrane composition affects fusion between cells and model membranes. Chem Biol Interact 2006, 164:167-173.
48. Ewert K.K., Evans H., Ahmad A., Slack L., Lin A., Martin-Herranz A., et al. Lipoplex structures and their distinct cellular pathways. Non-viral vectors for gene therapy, part I 2005, vol. 53:119-155. Elsevier Academic Press, San Diego. 2nd ed. L. Huang, M.C. Hung, E. Wagner (Eds.).
49. Tristram-Nagle S., Petrache H.I., Nagle J.F. Structure and interactions of fully hydrated dioleoylphosphatidylcholine bilayers. Biophys J 1998, 5:917-925.
50. Gruner S.M., Tate M.W., Kirk G.L., So P.T.C., Turner D.C., Keane D.T., et al. X-ray diffraction study of the polymorphic behavior of N-methylated dioleoylphosphatidylethanolamine. Biochemistry 1988, 27:2853-2866.
51. Zhang H.Y., Hill R.J. Concentration dependence of lipopolymer self diffusion in supported bilayer membranes. J R Soc Interface 2011, 8:127-143.
52. Israelachvili J. Intermolecular and surface forces 1992, Academic Press, London.
53. Roux D., Safinya C.R. A synchrotron x-ray study of competing undulation and electrostatic interlayer interactions in fluid multimembrane lyotropic phases. J Phys (Paris) 1988, 49:307-318.
54. deGennes P.G. Polymers at an interface; a simplified view. Adv Colloid Interface Sci 1987, 27:189-209.
55. Butt H.J., Kappl M., Mueller H., Raiteri R. Steric forces measured with the atomic force microscope at various temperatures. Langmuir 1999, 15:2559-2565.
56. Lim R.Y.H., Huang N.P., Koser J., Deng J., Lau K.H.A., Schwarz-Herion K., et al. Flexible phenylalanine-glycine nucleoporins as entropic barriers to nucleocytoplasmic transport. Proc Natl Acad Sci U S A 2006, 103:9512-9517.
57. Hansen P.L., Cohen J.A., Podgornik R., Parsegian V.A. Osmotic properties of poly(ethylene glycols): quantitative features of brush and bulk scaling laws. Biophys J 2003, 84:350-355.
58. Kenworthy A.K., Hristova K., Needham D., Mcintosh T.J. Range and magnitude of steric pressure between bilayers containing phospholipids with covalently attached poly(ethylene glycol). Biophys J 1995, 68:1921-1936.
59. Kuhl T.L., Leckband D.E., Lasic D.D., Israelachvili J.N. Modulation of interaction forces between bilayers exposing short-chained ethylene oxide headgroups. Biophys J 1995, 66:1479-1488.